Autres langues Shield Therapeutics plc

Actions

Marché Fermé - London S.E. Autres places de cotation 17:35:17 18/04/2024			Varia. 5j.	Varia. 1 janv.
1,475 ^GBX	-0,34 %		-6,35 %	-77,99 %

22/02	Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024
21/02	Le FTSE 100 est touché par les minutes du FOMC	AN

FTSE 100 takes hit ahead of FOMC minutes	21/02
Shield Therapeutics sinks as strong performance marred by data issues	21/02
Shield Therapeutics plc Announces Unaudited Sales Results for the Year Ended 31 December 2023	21/02
Shield Therapeutics hires former Akili leader as new CFO	09/01
Shield Therapeutics Names New CFO	09/01
Shield Therapeutics Appoints Santosh Shanbhag as New CFO, Effective January 16, 2024	09/01
Comptoir opens restaurant; Intercede wins contract	07/12
Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team	15/11
Shield to Present Abstract at 26th Annual Women's Healthcare Conference 2023 on Accrufer	23/10/23
FTSE 100 Ends Higher Fueled by Energy Stocks	12/10/23
Shield Therapeutics Chief Financial Officer Rudolf to leave	12/10/23
AIM WINNERS & LOSERS: Windward sees high contracting activity levels	12/10/23
Shield Therapeutics CFO to Step Down	12/10/23
Shield Therapeutics plc Announces Hans-Peter Rudolf Is Standing Down from His Role as Chief Financial Officer on 20 October 2023	12/10/23
Shield Therapeutics' pricing will be "key metric" - Proactive Research Analyst	05/10/23
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration	05/10/23
Aston Martin CEO ups stake; Alkemy's lithium deal	03/10/23
Shield Therapeutics completes USD20 million SWK financing	03/10/23
Shield Therapeutics Closes $20 Million Debt Facility with SWK Funding	03/10/23
EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joy	02/10/23

Aucun résultat pour cette recherche